Two Sigma Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $500K | Sell |
129,200
-135,100
| -51% | -$523K | ﹤0.01% | 1754 |
|
|
2025
Q1 | $1.32M | Buy |
264,300
+198,600
| +302% | +$993K | ﹤0.01% | 1336 |
|
|
2024
Q4 | $474K | Sell |
65,700
-22,700
| -26% | -$164K | ﹤0.01% | 1795 |
|
|
2024
Q3 | $543K | Buy |
88,400
+19,000
| +27% | +$117K | ﹤0.01% | 1665 |
|
|
2024
Q2 | $462K | Buy |
+69,400
| New | +$462K | ﹤0.01% | 1911 |
|
|
2023
Q4 | – | Sell |
-937,000
| Closed | -$2.44M | – | 2487 |
|
|
2023
Q3 | $2.44M | Sell |
937,000
-20,800
| -2% | -$54.1K | 0.01% | 1091 |
|
|
2023
Q2 | $3.38M | Buy |
957,800
+6,500
| +0.7% | +$22.9K | 0.01% | 941 |
|
|
2023
Q1 | $4.01M | Buy |
951,300
+26,000
| +3% | +$110K | 0.01% | 903 |
|
|
2022
Q4 | $15.2M | Buy |
925,300
+56,500
| +7% | +$929K | 0.04% | 406 |
|
|
2022
Q3 | $11.1M | Buy |
868,800
+102,200
| +13% | +$1.31M | 0.03% | 473 |
|
|
2022
Q2 | $8.97M | Buy |
766,600
+75,800
| +11% | +$887K | 0.03% | 543 |
|
|
2022
Q1 | $4.21M | Buy |
690,800
+133,600
| +24% | +$814K | 0.01% | 881 |
|
|
2021
Q4 | $5.1M | Buy |
+557,200
| New | +$5.1M | 0.01% | 758 |
|
|
2021
Q2 | – | Sell |
-236,200
| Closed | -$3.34M | – | 2435 |
|
|
2021
Q1 | $3.34M | Sell |
236,200
-108,400
| -31% | -$1.53M | 0.01% | 1037 |
|
|
2020
Q4 | $3.89M | Sell |
344,600
-147,300
| -30% | -$1.66M | 0.01% | 926 |
|
|
2020
Q3 | $6.49M | Buy |
+491,900
| New | +$6.49M | 0.02% | 677 |
|
|
2017
Q1 | – | Sell |
-115
| Closed | -$112K | – | 2331 |
|
|
2016
Q4 | $112K | Buy |
+115
| New | +$112K | ﹤0.01% | 2257 |
|